| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.8316 | 6 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.6923 | 40 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.3188 | 29 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.965 | 22 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.3646 | 34 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.8918 | 9 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.1701 | 33 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.8199 | 26 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.2798 | 19 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.3728 | 24 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.609 | 25 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.3546 | 38 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.4054 | 15 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.6952 | 26 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.3559 | 43 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.8212 | 31 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.0878 | 13 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 40.5412 | 8 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.3333 | 52 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.1188 | 33 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.3425 | 29 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.483 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.8044 | 40 |